ASHP House of Delegates Approves Professional Policies
During the 68th annual session of its House of Delegates in Baltimore earlier this month, the ASHP House of Delegates approved a professional policy calling on Congress to ban direct-to-consumer (DTC) advertising of prescription drugs and medication-containing devices. Delegates also approved policies supporting efforts by manufacturers and the Food and Drug Administration (FDA) to protect healthcare workers from exposure to hazardous drugs; expanded authority for the FDA to regulate the dissemination of information about off-label uses of medications; and the development and promotion of best practices for preventing drug diversion and reducing the incidence of controlled substance abuse. ASHP’s House of Delegates is the ultimate authority over the organization’s stance on important professional issues related to pharmacy practice and societal medication use. The House of Delegates meets annually at the ASHP Summer Meetings and virtually in March and November. In calling for a ban on DTC advertising, the House of Delegates shifted away from a policy of opposing DTC ads unless they meet certain criteria and instead adopted a policy calling for an outright ban on DTC advertising of prescription drugs and medication-containing devices. The new position by ASHP supersedes a policy that was first adopted in 1997.The House also approved the following professional policies:
ASHP Health-System Pharmacy Press Releases and Announcements
0 Comments